CRYSTAL MCCLAIN: Open Payments
NPI 1407586621 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,523 in 66 payments from 14 companies in 2025. Trend: 2023 $692 · 2024 $714 · 2025 $1,523
Food & beverage: $1,523
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $726 |
| Lilly USA, LLC | 13 | $225 |
| Phathom Pharmaceuticals, Inc. | 1 | $119 |
| E.R. Squibb & Sons, L.L.C. | 1 | $118 |
| Novo Nordisk Inc | 2 | $56 |
| Lundbeck LLC | 2 | $55 |
| PFIZER INC. | 3 | $54 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $45 |
| Exact Sciences Corporation | 2 | $34 |
| JAZZ PHARMACEUTICALS INC. | 1 | $20 |
Products named: VRAYLAR, QULIPTA, MOUNJARO, VOQUEZNA, COBENFY, ZEPBOUND, Wegovy, REXULTI.
Industry payments across NM — which companies pay providers there.
